37 min listen
Ep. 105: A Primer on Diagnostics-Related Congressional Legislation - Jennifer Leib
Ep. 105: A Primer on Diagnostics-Related Congressional Legislation - Jennifer Leib
ratings:
Length:
47 minutes
Released:
Mar 21, 2023
Format:
Podcast episode
Description
On this episode, Rich Thayer and Mickey Urdea are interviewing Jennifer Leib, founder of Innovation Policy Solutions, to dissect several key pieces of legislation related to the diagnostics industry. This episode was recorded in the last days of 2022 to capture the hot-off-the-presses developments at the end of the last session of Congress.
Jennifer Leib is a board-certified genetic counselor and experienced government affairs professional with an expertise in genomics and precision medicine policy, having studied at the undergraduate program at University of Michigan and the masters program at Johns Hopkins University.
Innovation Policy Solutions (iPolicy) is a leading government affairs consulting firm that promotes innovation through policy change. The firm actively advises and advocates on behalf of patients, providers, and innovators in laboratory medicine, precision medicine, public health, synthetic biology, gene therapy, neuroscience, rare diseases, and more. Grounded in a foundation of scientific expertise, iPolicy identifies data-driven solutions to health and science policy issues and builds coalitions of support to drive the adoption of clinical advances and enhance patient access to cutting-edge diagnostics and therapeutics. iPolicy is headquartered in Washington and supports clients across the country. For more information, visit www.ipolicysolutions.com.
Jennifer Leib is a board-certified genetic counselor and experienced government affairs professional with an expertise in genomics and precision medicine policy, having studied at the undergraduate program at University of Michigan and the masters program at Johns Hopkins University.
Innovation Policy Solutions (iPolicy) is a leading government affairs consulting firm that promotes innovation through policy change. The firm actively advises and advocates on behalf of patients, providers, and innovators in laboratory medicine, precision medicine, public health, synthetic biology, gene therapy, neuroscience, rare diseases, and more. Grounded in a foundation of scientific expertise, iPolicy identifies data-driven solutions to health and science policy issues and builds coalitions of support to drive the adoption of clinical advances and enhance patient access to cutting-edge diagnostics and therapeutics. iPolicy is headquartered in Washington and supports clients across the country. For more information, visit www.ipolicysolutions.com.
Released:
Mar 21, 2023
Format:
Podcast episode
Titles in the series (21)
Ep. 102: Global TB Diagnostics, Part 2 – Dr. Peter Small by Halteres Presents